alexa Clinical Evaluation of Mucin-1 (MUC1) and P16 in Laryngeal Cancer | OMICS International | Abstract
ISSN: 2161-119X

Otolaryngology: Open Access
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Clinical Evaluation of Mucin-1 (MUC1) and P16 in Laryngeal Cancer

Irmi Wiest1#, Christoph Alexiou2*, Klaus Friese1, Doris Mayr3, Christoph Freier1,4, Annika Stiasny1, Peter Betz5, Marina Pöttler2, Jutta Tübel6, Steffen Goletz7, Tobias Weißenbacher1, Darius Dian1, Udo Jeschke1 and Bernd Kost1


1Department of Obstetrics and Gynecology – Klinikum Innenstadt, Germany

2Department of Otorhinolaryngology, Head and Neck Surgery, Section for Experimental Oncology and Nanomedicine (SEON), Germany

3Department of Pathology, LMU, Germany

4Division of Clinical Pharmacology, LMU, Germany

5Department of Legal Medicine, FAU, Germany

6Department of Orthopedics, TUM, Germany

7Glycotope, Germany

# Author contributed equally

*Corresponding Author:
Christoph Alexiou
Department of Otorhinolaryngology
Head and Neck Surgery
Section for Experimental Oncology and Nanomedicine (SEON)
Else Kröner-Fresenius-Stiftung-Professorship
University Hospital Erlangen, Glückstr. 10a
Erlangen, Germany
Tel: +49 9131 85-33142
Fax: +49 9131 85-34808
E-mail: [email protected]

Received date: July 22, 2016; Accepted date: August 04, 2016; Published date: August 11, 2016

Citation: Wiest I, Alexiou C, Friese K, Mayr D, Freier C, et al. (2016) Clinical Evaluation of Mucin-1 (MUC1) and P16 in Laryngeal Cancer. Otolaryngol (Sunnyvale) 6:255. doi:10.4172/2161-119X.1000255

Copyright: ©2016 Wiest I, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Background: Adapted from results in the field of cervical cancer, a direct connection between HPV infection and oropharyngeal carcinoma development could be established. Aim of this study was to evaluate p16 and TA-MUC1 in laryngeal cancer and their correlation to diagnostic, since TA-MUC1 is primarily restricted to malignancies. Methods: Paraffin-embedded laryngeal cancer specimens (n=129) and normal tissue (n=5) were analyzed for TA-MUC1 expression using hPankoMab-GEXTM antibody and evaluated according the immunoreactive score. Survival was assessed via log-rank test and Kaplan-Meier-survival analysis. Results: Significant correlation with tumor grading and staging was exhibited by TA-MUC1staining, while being negative in normal tissues. Expression of p16 significantly increased in T4 compared to T1 tumors. Significant differences in overall survival were found in correlation to TNM-classification, grading and relapse. TA-MUC1 showed a positive trend correlating to p16. Conclusion: Because of this positive trend, we suggest a HPV association in head and neck tumors. Most likely due to an insufficient quantity of HPV-positive patients, no statistical significance could be established. However, targeting TA-MUC1 would improve tumor therapy by linking hPankoMab-GEXTM to the overexpressed galectin. Systematic analysis of HPV-association should be performed generally in laryngeal cancer to gain further information about the interaction of HPV and malignancies.


Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version